Increased expression of collagenase-3 (MMP-13) and MT1-MMP in oesophageal cancer is related to cancer aggressiveness

Gut

Volumn 47, Issue 1, 2000, Pages 50-56

  Etoh, T ^a   Inoue, H ^a   Yoshikawa, Y ^a   Barnard, G F ^b   Kitano, S ^c   Mori, M ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c OITA UNIVERSITY   (Japan)

Author keywords

Cancer aggressiveness; Collagenase 3; MT1 MMP; Oesophageal carcinoma; Prognosis

Indexed keywords

COLLAGENASE 3; ISOENZYME; MATRIX METALLOPROTEINASE; MESSENGER RNA;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, NORTHERN; BLOTTING, WESTERN; COLLAGENASES; ESOPHAGEAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; METALLOENDOPEPTIDASES; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; RNA, MESSENGER; RNA, NEOPLASM; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0033945337     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.47.1.50     Document Type: Article

References (33)

1. Sugimachi K, Matsuoka H, Ohnp S, et ai. Multivariate approach for assessing the prognosis of clinical oesophageal carcinoma. BrJSurg 1988;75:1115-18.
2. Isono K, Sato H, Nakayama K. Results of a nationwide study on the three-field lymph node dissection of esophageal cancer. Oncology 1991;4S:411-20.
3. Davies B, Vaxman J, Vasan H, ci al. Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. Cancer Res 1993;53:5365-9.
4. Mori M, Barnard GF, Mimori K, et al. Overexpression of matrix metalloproteinase-7 mRNA in human colon carcinomas. Cancer 1995;75:1516-19.
5. Sato H, Takino T, Okada Y, et al. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Mature 1994;370:61-5.
6. MacDougall JR, Matrisian LM. Contributions of tumour and stromal matrix metalloproteinases to tumour progression, invasion and metastasis! Cancer Metastasis Rev 1995;14:351-62.
7. Birkedal HH. Proteolytic remodeling of extracellular matrix. Curr Opin Cell Bio! 1995;7:728-35.
8. Birkedal HH, Moore VG, Bodden MK, al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993; 4:197-250.
9. Freije JM, Diez H, Baibin M, et al. Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J Biol Client 1994;269:16765-73.
10. Johansson N, Airola K, Grenman R, et al. Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck. Am j Palhol 1997;151:499-508.
11. Uria JA, Baibin M, Lopez JM, et al. Collagenase-3 (MMP13) expression in chondrosarcoma cells and its regulation by basic fibroblast growth factor. Am JPathol 1998;153:91101.
12. Uitto VJ, Airola K, Vaalamo M, et al. Collagenase-3 (matrix metalloproteinase-13) expression is induced in oral mucosal epithelium during chronic inflammation. AmJPathol 1998;152:1489-99.
13. Johansson N, Saarialho KU, Airola K, et al. Collagenase-3 (MMP-13) is expressed by hypertrophie chondrocytes, periosteal cells, and osteoblasts during human fetal bone development. DevDyn 1997;20S:387-97.
14. Vi ernicke D, Seyfert C, Hinzmann B, et al. Cloning of collagenase 3 from the synovial membrane and its expression in rheumatoid arthritis and osteoarthritis. J Rhcunmtol 1996:23:590-5.
15. Knauper V, Will H, Lopez OC, et al. Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase A (M.MP-2) are able to generate active enzyme. J Biol Chan 1996;271:17124-31.
16. Cowell S, Knauper V, Stewart ML, et al. Induction of matrix metalloproteinase activation cascades based on membranetype 1 matrix metalloproteinase: associated activation of gelatinase A, gelatinase B and collagenase 3. Biochem J 1998;lS:453-8.
17. Haupt LM, Thompson EW, Griffiths LR, Irving MG. IS-RT-PCR assay detection of MT-MMP in a human breast cancer cell line. Biochem Mol Biol Im 1996;39:55361.
18. Sato H, Okada Y, Seiki M. Membrane-type matrix metalloproteinases (MT-MMPs) in cell invasion. Thnmb Haemost 1997;78:497-500.
19. Mori M, Mimori K, Shiraishi T, et al. Analysis of MT1-MMP and MMP2 expression in human gastric cancers. Int 3 Cancer 1997; 74:316-21.
20. Caenazzo C, Onisto Ai, Sartor L, et al. Augmented membrane type 1 matrix metalloproteinase (MT1-A1MP): MMP-2 messenger RNA ratio in gastric carcinomas with poor prognosis. Clin Cancer Res 1998:4:2179-86.
21. Shima I, Sasaguri Y, Kusukawa J, ci al. Production of matrix metalloproteinase-2 and metaIloproteinase-3 related to malignant behavior of esophageal carcinoma. A clinicopathologic study. Cancer 1992;70:2747-53.
22. Otani Y, Okazaki I, Arai M, et al. Gene expression of interstitial collagenase (matrix metalloproteinase 1) in gastrointestinal tract cancers. J Gastroenterol 1994;29:391-7.
23. Murray GI, Duncan ME, O'Neil P, et al. Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer. J Pathol 1998;185:256-61.
24. Mori M, Barnard GF, Staniunas RJ, et al. Prothymosinalpha mRNA expression correlates with that of c-myc in human colon cancer. Oncogens 1993;S:2821-6.
25. Sato Y, Mukai K, Furuya S, et al. The AMeX method: a multipurpose tissue-processing and paraffin-embedding method. Extraction of protein and application to immunoboiung. Am J Patliol 1992;140:775-9.
26. Japanese Society of Esophageal Disease. Guide lines for the clinical and pathologic studies on carcinoma of the esophagus. JpnJSurg 1992:8:24-48. -,
27. Earlam R, Cunha MJ. Oesophageal squamous cell carcinoma: I. A critical review of surgery. Br J Surg 1980:67:381-90.
28. Yamashita K, Azumano I, Mai M, et al. Expression and tissue localization of matrix metalloproteinase 7 (matrilysin) in human gastric carcinomas. Implications for vessel invasion and metastasis. Int J Cancer 1998:79:187-94.
29. Kanayama H, Yokota K, Kurokawa Y, et al. Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer. Cancer 1998;S2:1359-66.
30. Tokuraku M, Sato H, Murakami S, et al. Activation of the precursor of gelatinase A/72 kDa type IV collagenase/ MMP-2 in lung carcinomas correlates with the expression of membrane-type matrix metalloproteinase (MT-MMP) and with lymph node metastasis. Int J Cancer 1995:64:3559.
31. Miyazaki K, Umenishi F, Funahashi K, et al. Activation of TIMP-2/progeIatinase A complex by stromelysin. Biochem Biophys Res Commun 1992;185:852-9.
32. Yamamoto M, Mohanam S, Sawaya R, et al. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro. Cancer Res 1996:56:384-92.
33. Okada A, Bellocq JP, Rouyer N, et al. Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc Nail Acad Sei USA 1995;92:2730-J.